Table of Contents Author Guidelines Submit a Manuscript
Research Article

MiR-92a inhibits the progress of osteosarcoma cells and increases the cisplatin sensitivity by targeting Notch1

Received 26 August 2017; Accepted 20 February 2018

Academic Editor: Paul W. Doetsch